May 8, 2013

Two NIMH Directors Debunk DSM & Deplore Psychiatry’s Unscientific Modus Operandi

After more than a dozen years during which we have been challenging psychiatry’s legitimacy as a medical

Read More
Two NIMH Directors Debunk DSM & Deplore Psychiatry’s Unscientific Modus Operandi

October 20, 2012

Are Psychiatrists Committing Professional Suicide?

TIME Psychiatrist Contends the Field Is ‘Committing Professional Suicide’ Psychiatry — and medicine in general — has

Read More
Are Psychiatrists Committing Professional Suicide?

September 14, 2012

Safety Issues: FDA Scientists Collide with FDA Managers

EXAMPLES demonstrating a collision between FDA safety officers and FDA leadership:   ·         In 1995, Dr. Leo

Read More
Safety Issues: FDA Scientists Collide with FDA Managers

September 8, 2012

FDA Scientists Collide with FDA Managers Re: Safety Issues

 EXAMPLES demonstrating a collision between FDA safety officers and FDA leadership:   In 1995, Dr. Leo Lutwak,

Read More
FDA Scientists Collide with FDA Managers Re: Safety Issues

May 14, 2012

Vicissitudes of Psychiatry’s Diagnostic Manual Revisions

The proposed revisions to the Diagnostic Statistical Manual (DSM) of the American Psychiatric Association will continue the

Read More
Vicissitudes of Psychiatry’s Diagnostic Manual Revisions

May 9, 2012

Who Is Not Fit To Practice Medicine?

A British Parliamentary Committee Report deemed Rupert Murdoch "not a fit person" to run a major news

Read More
Who Is Not Fit To Practice Medicine?

April 11, 2012

Why Eli Lilly’s Alzheimer’s Imaging Test- Amyvid- Is NO Breakthrough

The focus, in this instance, is not a therapeutic intervention, but rather a test using a radioactive

Read More
Why Eli Lilly’s Alzheimer’s Imaging Test- Amyvid- Is NO Breakthrough

July 21, 2011

Harvard Psychiatrists Disciplined for Conflicts of Interest

An investigation, prompted by Sen. Charles Grassely, was conducted by Harvard University-affiliated Massachusetts General Hospital. It concluded

Read More
Harvard Psychiatrists Disciplined for Conflicts of Interest

May 11, 2011

US Inspector General Report: Antipsychotic Drug Hazards

Antipsychotics are used primarily as chemical restraints to control behavior– not for any therapeutic, medically justifiable reason..

Read More
US Inspector General Report: Antipsychotic Drug Hazards

March 25, 2011

Jury Finds Johnson & Johnson Violated Consumer Protection Law

Johnson & Johnson lost another case involving its outrageously deceptive marketing of the antipsychotic, Risperdal. This time,

Read More
Jury Finds Johnson & Johnson Violated Consumer Protection Law

February 22, 2011

FDA MedWatch- Antipsychotics Class Label Change

The FDA has just issued an alert to healthcare professionals–in particular, psychiatrists and obstetricians about the serious

Read More
FDA MedWatch- Antipsychotics Class Label Change

January 14, 2011

The Truth Wears Off

The excerpts from The New Yorker (below) may be read as a companion piece to the Atlantic

Read More
The Truth Wears Off

October 3, 2010

Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

A New York Times report (below) reviews what has been accomplished by multiple civil and criminal lawsuits

Read More
Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

September 10, 2010

FDA Expands Market for Another Toxic Antipsychotic

According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic

Read More
FDA Expands Market for Another Toxic Antipsychotic